Andrew Dj Pearson, Claudia Rossig, Crystal Mackall, Nirali N Shah, Andre Baruchel, Gregory Reaman, Rosanna Ricafort, Delphine Heenen, Abraham Bassan, Michael Berntgen, Nick Bird, Eric Bleickardt, Najat Bouchkouj, Peter Bross, Carrie Brownstein, Sarah Beaussant Cohen, Teresa de Rojas, Lori Ehrlich, Elizabeth Fox, Stephen Gottschalk, Linda Hanssens, Douglas S Hawkins, Ivan D Horak, Danielle H Taylor, Courtney Johnson, Dominik Karres, Franca Ligas, Donna Ludwinski, Maksim Mamonkin, Lynley Marshall, Behzad K Masouleh, Yousif Matloub, Shannon Maude, Joe McDonough, Veronique Minard-Colin, Koen Norga, Karsten Nysom, Alberto Pappo, Laura Pearce, Rob Pieters, Martin Pule, Alfonso Quintás-Cardama, Nick Richardson, Martina Schüßler-Lenz, Nicole Scobie, Martina A Sersch, Malcolm A Smith, Jaroslav Sterba, Sarah K Tasian, Brenda Weigel, Susan L Weiner, Christian Michel Zwaan, Giovanni Lesa, Gilles Vassal
The seventh multi-stakeholder Paediatric Strategy Forum focused on chimeric antigen receptor (CAR) T-cells for children and adolescents with cancer. The development of CAR T-cells for patients with haematological malignancies, especially B-cell precursor acute lymphoblastic leukaemia (BCP-ALL), has been spectacular. However, currently, there are scientific, clinical and logistical challenges for use of CAR T-cells in BCP-ALL and other paediatric malignancies, particularly in acute myeloid leukaemia (AML), lymphomas and solid tumours...
January 2022: European Journal of Cancer